# A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

> **NCT03663946** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 81 (actual)

## Conditions studied

- Renal Cell Carcinoma
- Kidney Cancer

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT03663946
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-18
- **Primary completion:** 2020-05-30
- **Final completion:** 2020-05-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663946, "A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03663946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*